Equal THC and CBD Reduced Some Anxiety Ratings Without Eliminating THC Effects
Adding an equal dose of CBD reduced average self-rated anxiety compared with THC alone in a controlled vaporization study. The combination still increased anxiety on some comparisons, and the benefit was not uniform across baseline anxiety levels or measurement methods.
Four conditions in occasional cannabis users
Twenty-six healthy occasional users completed a randomized, double-blind crossover study of vaporized THC, CBD, their equal-dose combination and placebo. The target dose was 13.75 mg of each active cannabinoid when present.
The study assessed state anxiety using a questionnaire and a visual analog scale, alongside an emotional Stroop task. Blood cannabinoid measurements were in plasma. These endpoints should not be relabeled as a trial of anxiety-disorder treatment or an individual driving-impairment assay.
Less anxiety than THC alone was not no anxiety
On the state-anxiety questionnaire, both THC alone and THC/CBD increased anxiety compared with placebo. The combination produced less anxiety than THC alone. CBD by itself did not significantly differ from placebo.
Visual analog ratings showed a more conditional pattern. Baseline state and trait anxiety moderated responses to the combination. At high baseline state anxiety, CBD did not significantly counteract the THC effect; the pattern was more favorable at lower baseline anxiety.
The proportion experiencing lower anxiety also depended on the endpoint: most participants improved on the questionnaire comparison, whereas peak visual-analog responses were much more evenly divided. One headline percentage cannot represent every anxiety measure.
The cognitive task and concentration results add limits
The emotional Stroop task showed no significant treatment effect. That does not invalidate the subjective anxiety response, but it prevents a claim that all anxiety-related attention measures changed consistently.
Selected associations between anxiety and peak plasma THC or 11-hydroxy-THC appeared after THC alone, while other correlations were nonsignificant. Plasma measurements did not supply a universal anxiety threshold, especially when CBD was coadministered.
Why this is not a protection guarantee
The sample excluded anxiety disorders, used one dose and studied occasional users in a controlled setting. The questionnaire lacked a corresponding predose state assessment, and the emotional Stroop design and participants’ language backgrounds introduced additional limitations. On-road tests elsewhere in the parent protocol could also have influenced anticipation around assessment times.
The appropriate conclusion is that composition affected selected acute anxiety ratings under these conditions. It does not establish that CBD reliably prevents distress from THC, that all high-CBD products are behaviorally neutral or that feeling less anxious establishes safe driving.
Related analysis: Concentration Is Not Impairment: THC Blood Levels in California Driving Cases.
Primary research
Nadia R. P. W. Hutten and colleagues. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology (2022). DOI: 10.1007/s00213-022-06248-9.
